News & Press
How Marbles Health offers new path for depression, anxiety treatment
The Week India9/27/2025·09/27/25🌐 Asia
Summary
Marbles Health, an Indian health-tech startup, has developed EASE, India's first medically licensed portable tDCS device. EASE is CDSCO-approved for depression, anxiety, addiction, ADHD, chronic pain, and neuropsychiatric care. In trials at AIIMS Delhi, patients showed a 63.8% decrease in illness scores within two weeks. The device is 35% cheaper than foreign alternatives.
Why it matters
EASE represents India's first domestically developed and licensed neuromodulation device, making tDCS therapy more accessible and affordable in a country with significant mental health treatment gaps. The company has signed MoUs with the NHS in the UK for potential international expansion.
#tDCS#Mental Health Tech#Depression#Asia#Neurostimulation
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in